In a patient with a mediastinal recurrence following lobectomy for early stage NSCLC, what would be your treatment volume?
Would anyone consider elective mediastinal XRT to 45-50Gy then boost involved LN to 60-66? Or treat involved lymph node only? The patient will receive concurrent chemotherapy also. Any thoughts or suggestions would be greatly appreciated!
Answer from: Radiation Oncologist at Academic Institution
In a patient who develops an isolated failure in a regional nodal site after surgery, I would treat in a manner similar to inoperable stage III NSCLC (concurrent chemotherapy and radiation therapy). Under most circumstances, I would include some "selective" elective nodal coverage bas...
Comments
Radiation Oncologist at Mon Health I am on the precipice of seeing a patient with PET...
Answer from: Radiation Oncologist at Community Practice
When there is a relapse post surgery, salvage is a long shot. Dealing with post lobectomy versus post pneumonectomy provides different caveats. My/our goal at the University of Michigan dose escalation trial was practical: elective nodes made the target too large to conduct a dose escalation trial...
I am on the precipice of seeing a patient with PET...